The magnitude of the problem of chronic diseases (NCDs) in India is substantial and is growing

By EP News Bureau on November 7, 2014

Related Posts

Panel Discussion – Beyond generics: From Make in India to Innovate in India

Dr Bikash Kumar Nayak, Plant Head, Aurobindo Pharma

Mr Gurupyar Reddy, Head-Production Complex Injections, Dr Reddy’s Laboratories

Panel Discussion – Pharma 2035: Policies, partnerships and pathways to growth

Mr Vijay Kumar, Regional Manager-South, Sun Teknovation

Dr Shankar Varaganti, Commercial Marketing Manager, Merck Lifesciences

Mr Jyothi Venkata Prasad V, Head – QA API (Site-6), Biocon
Comments (0)
Add Comment